Status:
COMPLETED
Vaginal Microbiota and Its Association with Pap Smear Results, Human Papillomavirus, Vitamins, and Metabolic Mark
Lead Sponsor:
Cheng-Hsin General Hospital
Collaborating Sponsors:
Taipei Medical University
Conditions:
Vaginal Microbiome
Eligibility:
FEMALE
32-75 years
Brief Summary
The human microbiome, comprising bacteria, fungi, and viruses, plays a crucial role in host physiology, immune function, and disease susceptibility. While gut microbiota have been extensively studied,...
Detailed Description
Vaginal Microbiome, pH, Menopause, and Metabolic Factors The human body is colonized by a vast array of symbiotic, commensal, and pathogenic microorganisms, including bacteria, fungi, and viruses. Th...
Eligibility Criteria
Inclusion
- Participants must meet all of the inclusion criteria
- Female participants
- History of sexual activity
- Age 30 years or older
Exclusion
- Participants will be excluded from the study if they meet any of the following conditions:
- Currently pregnant at the time of enrollment or before sample collection day.
- History of total hysterectomy.
Key Trial Info
Start Date :
September 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 18 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT06897800
Start Date
September 8 2022
End Date
August 18 2023
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cheng Hsin General Hospital
Taipei, Taiwan, Taiwan, 112